The global amniocentesis needle market size is anticipated to reach USD 297.35 million by 2030, expanding at a CAGR of 6.85%, based on a new report by Grand View Research, Inc. This growth can be attributed to several factors like advancements in healthcare technology, a rising prevalence of genetic disorders prompting increased demand for prenatal diagnosis, and the continuous development of minimally invasive techniques. Amniocentesis needles are in high demand as they are essential for identifying potential risks. However, there is a pressing concern within the fields of obstetrics and gynecology regarding early pregnancy loss following amniocentesis.
The rise in genetic disorders worldwide is significantly boosting the demand for precise tools such as amniocentesis needles in prenatal diagnostics. This rising prevalence of genetic conditions highlights the pressing need for accurate and early detection methods for potential issues in unborn babies. The importance of advanced tools like amniocentesis needles is underscored by the growing demand for better prenatal care due to the serious health implications of genetic disorders. For instance, a 2022 report from MJH Life Sciences highlighted the escalating global burden of genetic diseases, revealing that around 300,000 babies are born with sickle cell disease annually, affecting nearly 5% of the world's population.
Gather more insights about the market drivers, restrains and growth of the Global Amniocentesis Needle Market
The trend of women delaying childbirth to older ages has gained prevalent traction. Advanced maternal age is inherently linked to a promoted risk of chromosomal abnormalities in the fetus, rendering amniocentesis comes in as a crucial diagnostic tool. The occurrence of early abortion following amniocentesis is a significant concern within the fields of obstetrics and gynecology. It's crucial to uncover the factors that contribute to this phenomenon. Studies have reported varying incidence rates, with some suggesting rates as high as around 10%. Consequently, this age-related factor significantly propels the demand for amniocentesis needles.
Furthermore, the increasing prevalence of chronic diseases such as diabetes and hypertension among expectant mothers has increased the demand for more comprehensive prenatal screening. According to a 2021 research paper published by The Global Library of Women’s Medicine, it is estimated that approximately 16.9% of pregnancies worldwide are affected by hyperglycemia during pregnancy, as per WHO criteria. The incidence of such conditions is on the rise, attributed to factors like the increasing obesity rate, advanced maternal age, and changes in screening and diagnostic criteria. Moreover, healthcare professionals increasingly acknowledge the importance of early detection of genetic disorders. Thus, amniocentesis is frequently recommended for women dealing with these health challenges, providing a crucial means to assess fetal health.
Amniocentesis Needle Market Report Highlights
List of Key Players in Amniocentesis Needle Market
Smith’s MedicalBiopsybell SrlIntegra LifeSciencesLaboratoire CCDCook MedicalMOS. SrlCooperSurgicalMedlineRocket MedicalBecton Dickinson and CompanyOrder a free sample PDF of the Amniocentesis Needle Market Intelligence Study, published by Grand View Research.
